Brain scans may help choose the right psychosis drug faster
NCT ID NCT07483294
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 120 people having their first episode of psychosis. They get brain scans and then take either risperidone or aripiprazole for 12 weeks. The goal is to see if brain scan patterns can predict who will respond well to which drug, potentially personalizing treatment early on.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- risperidone and aripiprazole
- What this could lead to
- If successful, this could lead to a way to predict which medication works best for a person with early psychosis, speeding up recovery and reducing trial-and-error.
- What could go wrong
- This is an early-stage observational study, not a treatment trial. The brain scan method may not reliably predict response, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOSIS; ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zucker Hillside Hospital
RECRUITINGGlen Oaks, New York, 11004, United States